Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey.
Autor: | Sadler D; Heart and Vascular Center, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA. SADLERD@ccf.org., DeCara JM; University of Chicago, Chicago, USA., Herrmann J; Mayo Clinic, Rochester, MN, USA., Arnold A; Lee Health, Ft. Myers, USA., Ghosh AK; Barts Heart Centre, St Bartholomew's Hospital, and University College London's Hospital, London, UK., Abdel-Qadir H; Women's College Hospital and Peter Munk Cardiac Centre, University of Toronto, Toronto, Canada., Yang EH; UCLA Cardio-Oncology Program, University of California, Los Angeles, USA., Szmit S; Centre of Postgraduate Medical education, Warsaw, Poland., Akhter N; Northwestern Feinerg School of Medicine, Chicago, USA., Leja M; University of Michigan, Ann Arbor, MI, USA., Silva CMPDC; University of Sao Paulo, Sao Paulo, Brazil., Raikhelkar J; Columbia University Irving Medical Center, New York, NY, USA., Brown SA; Medical College of Wisconsin, Milwaukee, WI, USA., Dent S; Duke University, Durham, NC, USA., O'Quinn R; University of Pennsylvania, Philadelphia, PA, USA., Thuny F; Aix-Marseille University, Marseille, France., Moudgil R; Cleveland Clinic, Cleveland, OH, USA., Raez LE; Memorial Health Care, Florida International University, Miami, FL, USA., Okwuosa T; Rush University Medical Center, Chicago, IL, USA., Daniele A; Roffo Institute, Buenos Aires, Argentina., Bauer B; Torrance Memorial Medical Center, Torrance, CA, USA., Kondapalli L; University of Colorado, Aurora, CO, USA., Ismail-Khan R; H. Lee Moffitt Cancer Center, Tampa, FL, USA., Lax J; Hospital Cosme Argerich, Buenos Aires, Argentina., Blaes A; University of Minnesota, Minneapolis, MN, USA., Nahleh Z; Heart and Vascular Center, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA., Elson L; Heart and Vascular Center, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA., Baldassarre LA; Yale School of Medicine, New Haven, CT, USA., Zaha V; UT Southwestern, Dallas, TX, USA., Rao V; Franciscan Health, Indianapolis, IN, USA., Lara DS; Instituto Nacional de Cardiologia, Ciudad de Mexico, Mexico., Skurka K; Franciscan Health, Indianapolis, IN, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Cardio-oncology (London, England) [Cardiooncology] 2020 Nov 27; Vol. 6 (1), pp. 28. Date of Electronic Publication: 2020 Nov 27. |
DOI: | 10.1186/s40959-020-00085-5 |
Abstrakt: | Background: Re-allocation of resources during the COVID-19 pandemic has resulted in delays in care delivery to patients with cardiovascular disease and cancer. The ability of health care providers to provide optimal care in this setting has not been formally evaluated. Objectives: To assess the impact of COVID-19 resource re-allocation on scheduling, testing, elective procedures, telemedicine access, use of new COVID-19 therapies, and providers' opinions on healthcare policies among oncology and cardiology practitioners. Methods: An electronic survey was conducted by a cardio-oncology collaborative network through regional and state chapters of the American College of Cardiology, American Society of Clinical Oncology, and the International Cardio-Oncology Society. Descriptive statistics were reported by frequency and proportion for analyses, and stratified categorically by geographic region and specialty. Results: One thousand four hundred fifteen providers (43 countries) participated: 986 cardiologists, 306 oncologists, and 118 trainees/internal medicine. 63% (195/306) of oncologists vs 92% (896/976) of cardiologists reported cancellations of treatments/elective procedures (p = 0.01). 46% (442/970) of cardiologists and 25% (76/303) of oncologists modified the scope of their practice (p = < 0.001). Academic physicians (74.5%) felt better supplied with personal protective equipment (PPE) vs non-academic (74.5% vs 67.2%; p = 0.018). Telemedicine was less common in Europe 81% (74/91), and Latin America 64% (101/158), than the United States, 88% (950/1097) (p = < 0.001). 95% of all groups supported more active leadership from medical professional societies. Conclusions: These results support initiatives to promote expanded coverage for telemedicine, increased access to PPE, better testing availability and involvement of medical professional societies to help with preparedness for future health care crisis. |
Databáze: | MEDLINE |
Externí odkaz: |